DeepMed Research

statin

Generic Name: statin

Clinical Trials

PCSK9 Inhibitor with Statin Therapy for Asymptomatic Intracranial Atherosclerosis

Phase 4

Not yet recruiting

Conditions: Intracranial Atherosclerosis
Intracranial Artery Stenosis
Atherosclerotic Plaque

Interventions: Drug: Recaticimab and Statin
Drug: Statin

First Posted Date: 2025-03-30

Last Posted Date: 2025-03-30

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 300

Registration Number: NCT06902740

Locations: 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China
🇨🇳
Hebei Provincial People's Hospital, Shijiazhuang, Hebei, China

and more 7 locations

Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study

Recruiting

Conditions: Ischemic Stroke
TIA

Interventions: Drug: Statin

First Posted Date: 2025-01-21

Last Posted Date: 2025-01-21

Lead Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Target Recruit Count: 300

Registration Number: NCT06785740

Locations: 🇳🇱
Flevoziekenhuis, Almere, Netherlands
🇳🇱
Amsterdam UMC, location AMC, Amsterdam, Netherlands
🇳🇱
Catharina Ziekenhuis, Eindhoven, Netherlands

and more 1 locations

Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)

Recruiting

Conditions: Acute Coronary Syndromes

Interventions: Drug: PCSK9 inhibitor
Drug: Statin+Ezetimibe/Hybutimibe compound
Drug: Statin

First Posted Date: 2024-12-18

Last Posted Date: 2025-03-17

Lead Sponsor: Yun Dai Chen

Target Recruit Count: 6000

Registration Number: NCT06738758

Locations: 🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China

Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)

Not Applicable

Not yet recruiting

Conditions: Myocardial Ischaemic Syndrome
Coronary Heart Disease

Interventions: Drug: Statin
Drug: PCSK9 inhibitor

First Posted Date: 2024-12-12

Last Posted Date: 2024-12-12

Lead Sponsor: Nanjing Medical University

Target Recruit Count: 400

Registration Number: NCT06730802

Locations: 🇨🇳
Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke

Recruiting

Conditions: Ischemic Stroke
Lipid Disorder
Atherosclerosis of Artery
Statin

Interventions: Drug: Statin
Drug: Probucol

First Posted Date: 2024-09-19

Last Posted Date: 2025-03-25

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 200

Registration Number: NCT06604117

Locations: 🇨🇳
Xuanwu Hospital, Xicheng District, Beijing, China

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Phase 1

Recruiting

Conditions: Solid Tumors
Ototoxicity

Interventions: Other: placebo
Drug: Statin

First Posted Date: 2024-08-14

Last Posted Date: 2025-02-14

Lead Sponsor: Minia University

Target Recruit Count: 60

Registration Number: NCT06553157

Locations: 🇪🇬
Minia University hospital, department of oncology and nuclear medicine, Minya, Egypt

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography

Phase 4

Recruiting

Conditions: Coronary Artery Disease
Optical Coherence Tomography

Interventions: Drug: PCSK9 inhibitor
Drug: Statin

First Posted Date: 2024-07-25

Last Posted Date: 2024-08-19

Lead Sponsor: First Affiliated Hospital of Xinjiang Medical University

Target Recruit Count: 396

Registration Number: NCT06520904

Locations: 🇨🇳
First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China

An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer

Phase 2

Recruiting

Conditions: Ovarian Cancer

Interventions: Drug: Sugar pill
Drug: Statin

First Posted Date: 2024-06-21

Last Posted Date: 2024-06-21

Lead Sponsor: Anhui Provincial Cancer Hospital

Target Recruit Count: 500

Registration Number: NCT06468254

Locations: 🇨🇳
Anhui Cancer Hospital, Hefei, Anhui, China

Statins and Post-ERCP Acute Pancreatitis (Stark Project)

Completed

Conditions: Post-ERCP Acute Pancreatitis

Interventions: Drug: Statin

First Posted Date: 2024-04-16

Last Posted Date: 2024-04-16

Lead Sponsor: Hospital General Universitario de Alicante

Target Recruit Count: 1016

Registration Number: NCT06367322

Locations: 🇪🇸
Alicante, Alicante, Spain
🇪🇸
Hospital General Universitario de Alicante, Alicante, Spain

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)

Phase 4

Withdrawn

Conditions: Atherosclerosis
Coronary Artery Disease
Heart Attack

Interventions: Drug: Statin
Drug: Aspirin tablet
Drug: Nexlizet
Drug: LEQVIO
Drug: Vascepa
Drug: Jardiance
Drug: Colchicine

First Posted Date: 2024-02-28

Last Posted Date: 2025-03-17

Lead Sponsor: University of Louisville

Target Recruit Count: 200

Registration Number: NCT06280976

Locations: 🇺🇸
University of Louisville School of Medicine, Division of Cardiovascular Diseases, Louisville, Kentucky, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy